Your browser doesn't support javascript.
loading
Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin.
Dürr, Claudia; Hanna, Bola S; Schulz, Angela; Lucas, Fabienne; Zucknick, Manuela; Benner, Axel; Clear, Andrew; Ohl, Sibylle; Öztürk, Selcen; Zenz, Thorsten; Stilgenbauer, Stephan; Li-Weber, Min; Krammer, Peter H; Gribben, John G; Lichter, Peter; Seiffert, Martina.
Affiliation
  • Dürr C; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hanna BS; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schulz A; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lucas F; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Zucknick M; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, UK.
  • Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Clear A; Oslo Center for Biostatistics and Epidemiology; Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Norway.
  • Ohl S; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Öztürk S; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, UK.
  • Zenz T; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Stilgenbauer S; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Li-Weber M; Molecular Therapy in Haematology and Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), and Department of Medicine V, University Hospital Heidelberg, Germany.
  • Krammer PH; Internal Medicine III, University of Ulm, Germany.
  • Gribben JG; Division of Immunogenetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lichter P; Division of Immunogenetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Seiffert M; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, UK.
Haematologica ; 103(4): 688-697, 2018 04.
Article in En | MEDLINE | ID: mdl-29326123
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Signal Transduction / Receptors, Tumor Necrosis Factor / Flavanones Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Haematologica Year: 2018 Document type: Article Affiliation country: Alemania Country of publication: Italia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Signal Transduction / Receptors, Tumor Necrosis Factor / Flavanones Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Haematologica Year: 2018 Document type: Article Affiliation country: Alemania Country of publication: Italia